menu
    • menu

    Company profile for Corvus Pharmaceuticals

    NEW Drugs in Dev: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers, including refractory renal cell carcinoma and non-small cell lung cancer. Our seasoned team of biopharma industry leaders are dedicated to developing new oncology medicines for patie...
    Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers, including refractory renal cell carcinoma and non-small cell lung cancer. Our seasoned team of biopharma industry leaders are dedicated to developing new oncology medicines for patients in need. Their successful track record of discovering, developing and commercializing innovative therapies for patients with serious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Corvus PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    863 Mitten Road, Suite 102 Burlingame, CA
    Telephone
    Telephone
    650-900-4520
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Pharma Updates Business And Releases 2025 Financials
    Corvus Pharma Updates Business And Releases 2025 Financials

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255077/0/en/Corvus-Pharmaceuticals-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Corvus Pharma Reports Q4 & FY 2025 Results March 12, 2026
    Corvus Pharma Reports Q4 & FY 2025 Results March 12, 2026

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250632/0/en/Corvus-Pharmaceuticals-to-Provide-Business-Update-and-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-12-2026.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Corvus To Present At Oppenheimer Healthcare Life Sciences Conf
    Corvus To Present At Oppenheimer Healthcare Life Sciences Conf

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3243012/0/en/Corvus-Pharmaceuticals-to-Present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Corvus Pharma Closes Stock Offering, Raises $201M
    Corvus Pharma Closes Stock Offering, Raises $201M

    23 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/23/3225093/0/en/Corvus-Pharmaceuticals-Announces-Closing-of-Upsized-Public-Offering-of-Common-Stock-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares-Generating-Gross-Proc.html

    GLOBENEWSWIRE
    23 Jan 2026
    Share Share
    Corvus Pharma Plans Public Stock Offering & Pre-Funded Warrants
    Corvus Pharma Plans Public Stock Offering & Pre-Funded Warrants

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3222239/0/en/Corvus-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Corvus Pharma Confirms Positive Phase 1 Trial Data
    Corvus Pharma Confirms Positive Phase 1 Trial Data

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221554/0/en/Corvus-Pharmaceuticals-Announces-Positive-Data-from-Cohort-4-Confirming-Results-for-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search